Rigg, Khary, PhD
Khary Rigg, Ph.D., is an Associate Professor in the Department of Mental Health Law & Policy at University of South Florida. He is a behavioral health services and policy researcher with over 15 years of experience studying substance use disorders. He earned his Ph.D. in medical sociology from University of Miami and completed a post-doctoral fellowship in health services research at the University of Pennsylvania Perelman School of Medicine. Dr. Rigg also has appointments in the Department of Sociology and the Florida Mental Health Institute.
His research is focused on understanding drugs and the people who use them. A common theme throughout his work is a concern for the health and well-being of people with addictive disorders. Dr. Rigg’s studies generate findings that support effective clinical practice across healthcare and community settings. He is also passionate about bridging the gap between research and drug policy.
Dr. Rigg specializes in community-based participatory research approaches, qualitative and mixed-methods designs, and has been involved in numerous studies using focus groups, in-depth interviewing, and photovoice. His work also involves secondary analysis of large datasets to identify substance use trends and risk factors. He is currently Associate Editor of Substance Use & Misuse, and serves on the editorial boards for Psychology of Addictive Behaviors, Drug & Alcohol Dependence, Harm Reduction Journal, and Qualitative Social Work.
• B.S., Florida International University
• M.S., University of Miami
• Ph.D., University of Miami
• Drug Prevention, Treatment, Harm Reduction
• Opioid Addiction and Overdose
• Community-Based Interventions/Research
• Club Drug Use/Drug-Related HIV Transmission
• Mixed Methods/Qualitative Research
Rigg, K. K., & Rigg, M. S. (2020). Opioid-induced hearing loss and neonatal abstinence syndrome: Clinical considerations for audiologists and recommendations for future research. American Journal of Audiology. Published online.
Chavez, M. & Rigg, K. K. (2020). Nutritional implications of opioid use disorder: A guide for drug treatment providers. Psychology of Addictive Behaviors. Published online.
Johnson, K., Rigg, K. K., & Eyles-Hopkins, C. (2020). Receiving addiction treatment in the US: Do patient demographics, drug of choice, or substance use disorder severity matter?International Journal of Drug Policy, 75, 89-98.
Rigg, K. K., & Nicholson, H. (2019). Prescription opioid misuse among African-American adults: A rural-urban comparison of prevalence and risk. Drug & Alcohol Dependence, 197, 191-196.
McLean, K., Monnat, S., Rigg, K. K., Sterner, G., & Verdery, A. (2019). “You never know what you’re getting”: Opioid users’ perceptions of fentanyl in southwest Pennsylvania. Substance Use & Misuse. 54(6), 955-966.
Rigg, K. K.,McLean, K., Monnat, S. M., Sterner, G. E., & Verdery, A. M. (2018). Opioid misuse initiation: Implications for intervention. Journal of Addictive Diseases, 37(3-4), 111-122.
Rigg, K. K., Monnat, S., & Chavez, M. (2018). Opioid-related mortality in rural America:Geographic heterogeneity and intervention strategies. International Journal of Drug Policy, 57, 119-129.
Rigg, K. K., & Menendez, K. (2018). Drug prevention programs in schools: Selecting program providers. Health Education Journal, 77(5), 586-597.
Szalavitz, M., & Rigg, K. K. (2017). The curious (dis)connection between the opioid epidemic and crime. Substance Use & Misuse. 49(14), 1927-1931.
Monnat, S. M., & Rigg, K. K. (2016). Examining rural/urban differences in prescription opioid misuse among U.S. adolescents. Journal of Rural Health, 32(2), 204–218.
Ford, J. A., & Rigg, K. K. (2015). Racial/ethnic differences in factors that place adolescents at risk for prescription opioid misuse. Prevention Science, 16(5), 633-641.
Rigg, K. K., & Monnat, S. M. (2015). Comparing characteristics of prescription painkiller misusers and heroin users in the United States. Addictive Behaviors, 51, 106-112.
Rigg, K. K., & Monnat, S. M. (2015). Urban vs. rural differences in prescription opioid misuse among adults in the United States: Informing region-specific drug policies and interventions. International Journal of Drug Policy, 26, 484-491.
Rigg, K. K., & Ford, J. (2014). The misuse of benzodiazepines among adolescents: Psychosocial risk factors in a national sample. Drug & Alcohol Dependence, 137(1), 137-142.
Rigg, K. K., & DeCamp, W. (2014). Explaining prescription opioid misuse among veterans: A theory-based analysis using structural equation modeling. Military Behavioral Health, 2(2), 210-216.
Rigg, K. K., & Murphy, J. W. (2013). Understanding the etiology of prescription opioid abuse: Implications for prevention and treatment. Qualitative Health Research,23(7), 963-975.
Ibañez, G. E., Levi-Minzi, M., Rigg, K. K., & Mooss, A. D. (2013). Diversion of benzodiazepines through healthcare sources. Journal of Psychoactive Drugs, 45(1), 48–56.
Rigg, K. K., Kurtz, S. P., & Surratt, H. L. (2012). Patterns of prescription medication diversion among drug dealers. Drugs: Education, Prevention & Policy, 19(2), 145-155.
Rigg, K. K., & Ibañez, G. E. (2010). Motivations for non-medical prescription drug use: A mixed methods analysis. Journal of Substance Abuse Treatment, 39(3), 236-247.
Rigg, K. K., March, S., & Inciardi, J. A. (2010). Prescription drug abuse and diversion: Role of the pain clinic. Journal of Drug Issues, 40(3), 681-702.
Community-Based Health Interventions/Research
Rigg, K. K., & Kosyluk, K. (2020). Developing and evaluating community-based health interventions: The role of data. In Jung Choi (Eds.), Community-based Service Delivery and Programs. New York, NY: Routledge.
Rigg, K. K., McNeish, R., & Schadrac, D. (2019). Community needs of minority male youth living in inner-city Chicago. Children and Youth Services Review. 98, 284-289.
Rigg, K. K., Sharp, A., Conner, K., Moore, K. (2019). A new role for patients in community-based health interventions. In Steven Arxer & John Murphy (Eds.), Community-based Health Interventions in an Institutional Context. New York, NY: Springer.
McNeish, R., Rigg, K. K., & Tran, Q. (2019). Community-based behavioral health interventions: Developing strong community partnerships. Evaluation & Program Planning, 73, 111-115.
Rigg, K. K., Engelman, D., & Ramirez, J. (2018). A community-based approach to primary health care. In Steven Arxer & John Murphy (Eds.), International Perspectives on Social Policy, Administration, and Practice (pp. 105-117). New York, NY: Springer.
Murphy, J. W., & Rigg, K. K. (2016). Rethinking causality in the social sciences: Implications for research and health interventions. In Jared A. Jaworski (Ed.), Advances in Sociology Research (pp. 1-12). New York, NY: Nova Science Publishers.
Club Drug Use/Harm Reduction
Rigg, K. K., & Mills, A. (2020). Sexual risk behaviors among African-Americans who use MDMA (molly/ecstasy): Implications for HIV prevention. Social Work in Public Health.Published online.
Rigg, K. K., & Sharp, A. (2018). Deaths related to MDMA (ecstasy/molly): Prevalence, root causes, and harm reduction interventions. Journal of Substance Use, 23(4), 345-352.
Rigg, K. K., & Lawental, M. (2018). Perceived risk associated with MDMA (ecstasy/molly) use among African-Americans. Substance Use & Misuse, 53(7), 1076-1083.
Rigg, K. K.(2018). MDMA (ecstasy/molly) use among African-Americans: Patterns of initiation. International Journal of Mental Health & Addiction, 16(3), 662-671.
Rigg, K. K., & Sharp, A. (2018). Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction. Addictive Behaviors, 79, 159-165.
Rigg, K. K., & Estreet, A. (2018). MDMA (ecstasy/molly) use among African-Americans: The perceived influence of hip-hop/rap music. Journal of Ethnicity in Substance Abuse, 18(4), 667-677.
Lawental, M., Kipnis, A., & Rigg, K. K. (2018). Binge drinking in young adults: Application of the theory of planned behavior. Psychology, Health & Medicine, 23(9), 1-9.
Rigg, K. K.(2017). Motivations for MDMA (ecstasy/molly) use among African-Americans: Implications for prevention and harm reduction programs. Journal of Psychoactive Drugs, 49(3), 192-200.